Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.84 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.84 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.81 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.81 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.81 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.81 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.81 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.81 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.81 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.81 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.81 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.81 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.81 |
| ▸ | EGFR | P00533 | 2/20 | 0.79 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.79 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.79 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.79 |
| ▸ | PRKCG | P05129 | 1/20 | 0.79 |
| ▸ | PRKACA | P17612 | 1/20 | 0.79 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11900090 | 0.92 | HDAC6 (0.85) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL3025457 | 0.91 | HDAC6 (0.91) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL6386658 | 0.90 | HDAC6 (1.00) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL1912347 | 0.89 | HDAC6 (0.80) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL1926318 | 0.89 | EPHX2 (0.77) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL539269 | 0.89 | MMP13 (1.00) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL4981515 | 0.89 | EPHX2 (0.77) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL1927145 | 0.89 | EPHX2 (0.77) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL3812691 | 0.89 | ROCK2 (1.00) | EPHX2NR1H4HDAC6HDAC2HDAC8 | |
| SCHEMBL457082 | 0.88 | HDAC6 (0.79) | EPHX2NR1H4HDAC6HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9463451-B2 | Ligand, metal complex containing ligand, and reaction using metal complex containing ligand | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9463451-B2 | Ligand, metal complex containing ligand, and reaction using metal complex containing ligand | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-04-21 | — | — | US | disclosed |
| WO-2013028445-A1 | FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2013-02-28 | — | — | WO | disclosed |
| WO-2012102247-A1 | RUTHENIUM COMPLEX-CONTAINING CATALYST FOR HYDROGEN TRANSFER REACTION AND METHOD FOR PRODUCING HYDROGEN TRANSFER REACTION PRODUCT | 国立大学法人名古屋大学 (JP) | 2012-08-02 | — | — | WO | disclosed |
| EP-1836169-B9 | COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS | KINEX PHARMACEUTICALS LLC (US) | 2012-07-04 | — | — | EP | disclosed |
| EP-1836169-B1 | COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS | KINEX PHARMACEUTICALS LLC (US) | 2012-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | HRH3, HRH2, HRH4 | EPHX2 1652/4885NR1H4 371/4885HDAC6 3672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.